These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 37233460)

  • 1. Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges.
    Tramontano C; De Stefano L; Rea I
    Mar Drugs; 2023 Apr; 21(5):. PubMed ID: 37233460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles: Attractive tools to treat colorectal cancer.
    Younis NK; Roumieh R; Bassil EP; Ghoubaira JA; Kobeissy F; Eid AH
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1-13. PubMed ID: 36028154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
    Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnologies for the treatment of colon cancer: From old drugs to new hope.
    Kotelevets L; Chastre E; Desmaële D; Couvreur P
    Int J Pharm; 2016 Nov; 514(1):24-40. PubMed ID: 27863668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research advances in nanomedicine applied to the systemic treatment of colorectal cancer.
    Yin L; Li H; Shi L; Chen K; Pan H; Han W
    Int J Cancer; 2023 Mar; 152(5):807-821. PubMed ID: 35984398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer.
    Guo Y; Wang M; Zou Y; Jin L; Zhao Z; Liu Q; Wang S; Li J
    J Nanobiotechnology; 2022 Aug; 20(1):371. PubMed ID: 35953863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diatoms Green Nanotechnology for Biosilica-Based Drug Delivery Systems.
    Terracciano M; De Stefano L; Rea I
    Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30463290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer.
    Yang G; Cao Y; Yang X; Cui T; Tan NZV; Lim YK; Fu Y; Cao X; Bhandari A; Enikeev M; Efetov S; Balaban V; He M
    Exp Mol Pathol; 2024 Jun; 137():104904. PubMed ID: 38788248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
    Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
    Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Delivery through Epidermal Tissue Cells by Functionalized Biosilica from Diatom Microalgae.
    Vona D; Flemma A; Piccapane F; Cotugno P; Cicco SR; Armenise V; Vicente-Garcia C; Giangregorio MM; Procino G; Ragni R
    Mar Drugs; 2023 Aug; 21(8):. PubMed ID: 37623719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review.
    Ali DS; Othman HO; Anwer ET
    Curr Pharm Biotechnol; 2023; 24(12):1554-1559. PubMed ID: 36733239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of nanoscale drug delivery systems for colorectal cancer liver metastasis.
    Hong Y; Rao Y
    Biomed Pharmacother; 2019 Jun; 114():108764. PubMed ID: 30901717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
    Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
    Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SERS Quantification of Galunisertib Delivery in Colorectal Cancer Cells by Plasmonic-Assisted Diatomite Nanoparticles.
    Managò S; Tramontano C; Delle Cave D; Chianese G; Zito G; De Stefano L; Terracciano M; Lonardo E; De Luca AC; Rea I
    Small; 2021 Aug; 17(34):e2101711. PubMed ID: 34302422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
    Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
    Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
    Wang K; Shen R; Meng T; Hu F; Yuan H
    Molecules; 2022 May; 27(9):. PubMed ID: 35566331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Toxicity Assessment of Hybrid Diatomite Nanovectors Using Hydra vulgaris as a Model System.
    Terracciano M; De Stefano L; Tortiglione C; Tino A; Rea I
    Adv Biosyst; 2019 Apr; 3(4):e1800247. PubMed ID: 32627433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome technologies towards colorectal cancer therapeutics.
    Sang R; Stratton B; Engel A; Deng W
    Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Armamentarium in Drug Delivery for Colorectal Cancer.
    Ali A; Akhtar J; Ahmad U; Basheer AS; Jaiswal N; Jahan A
    Crit Rev Ther Drug Carrier Syst; 2022; 40(1):1-48. PubMed ID: 36374840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.